Role of new drugs for management of atrial fibrillation.
CONCLUSIONS: Use of dronedarone should be limited to patients with paroxysmal or persistent AF and should not be used in patients with heart failure or with permanent AF. Newer antithrombotic agents appear to be promising alternatives for the prevention of stroke in patients with AF; however, more data are needed to understand their role.
PMID: 23249869 [PubMed - in process]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Hollands JM, Gowan M, Riney JN, Deal EN, Kates AM Tags: Ann Pharmacother Source Type: research
More News: Amiodarone | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Clinical Trials | Coumadin | Drugs & Pharmacology | Gastroenterology | Heart | Heart Attack | Heart Failure | Stroke | Study | Warfarin